MEDICO vs RPGLIFE: Stock Comparison

Medico Remedies Limited vs RPG Life Sciences Limited

Live data: 22 July 2026, 2:58 PM IST • Source: NSE and company filings

RPG Life Sciences Limited is the larger company by market capitalisation. Medico Remedies Limited shows a lower P/E and faster revenue growth, while RPG Life Sciences Limited shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Medico Remedies Limited and RPG Life Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, MEDICO is more favourable on 6 of 13 scored metrics and RPGLIFE on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
RPGLIFE is the larger company
₹4,948 Cr vs ₹317 Cr
P/E Ratio
MEDICO has a lower P/E
27.22x vs 43.37x
P/B Ratio
MEDICO has a lower P/B
4.73x vs 8.25x
EPS
RPGLIFE has higher earnings per share
₹69.65 vs ₹1.58
Dividend Yield
RPGLIFE has a higher dividend yield
0.75% vs 0%
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs 23.6%
EPS Growth (TTM YoY)
MEDICO has faster EPS growth
36.5% vs -74.5%
Qtr Sales Growth
MEDICO has stronger quarterly sales growth
37.6% vs 23.6%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDICORPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMEDICORPGLIFE
Live Price₹38.78₹3,006.8
Day Change0.41%0.3%
Volume19,04730,013
52-Week High₹56.88₹3,082
52-Week Low₹30.22₹1,733
Distance from 52W High-31.82%-2.44%

Valuation

MetricMEDICORPGLIFE
Market Cap₹317 Cr₹4,948 Cr
P/E Ratio27.22x43.37x
P/B Ratio4.73x8.25x
EPS₹1.58₹69.65
Book Value₹9.15₹366.04
Dividend Yield0%0.75%

Growth

MetricMEDICORPGLIFE
Revenue Growth (TTM YoY)37.5%23.6%
EPS Growth (TTM YoY)36.5%-74.5%
Qtr Sales Growth37.6%23.6%
Qtr Profit Growth35%33.7%

Profitability & Leverage

MetricMEDICORPGLIFE
ROE19%19.3%
ROCE23.1%25.7%
Net Margin6.36%29.25%
Operating Margin8.25%20.9%
Debt to Equity0.25x0.03x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricMEDICORPGLIFE
Promoter Holding61.38%72.95%
FII Holding0.03% 0.46 pp0.87% 0.13 pp
DII Holding0%7.45% 0.41 pp
Public Holding38.59% 0.46 pp18.73% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Medico Remedies Limited and RPG Life Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.